Oric Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

ORIC Pharmaceuticals

21/03/2022 21:01

* Oric Pharmaceuticals Inc  ORIC.OQ  reported a quarterly
adjusted
loss of 58 cents​​ per share for the quarter ended in December.
The mean expectation of seven analysts for the quarter was for a
loss of 57 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Oric Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 58 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Oric Pharmaceuticals Inc shares had fallen by 53.9% this
quarter.
    * The company reported a quarterly loss of $22.77 million.
    * Wall Street's median 12-month price target for Oric
Pharmaceuticals Inc is $31.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 7 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated March 21 at 09:00 p.m.  ​All
figures in US dollars unless otherwise stated